Breast cancer patient-derived organoids for the investigation of patient-specific tumour evolution

Abstract Background A reliable preclinical model of patient-derived organoids (PDOs) was developed in a case study of a 69-year-old woman diagnosed with breast cancer (BC) to investigate the tumour evolution before and after neoadjuvant chemotherapy and surgery. The results were achieved due to the...

Full description

Bibliographic Details

Published in:	Cancer Cell International
Main Authors:	Serena Mazzucchelli, Lorena Signati, Letizia Messa, Alma Franceschini, Arianna Bonizzi, Lorenzo Castagnoli, Patrizia Gasparini, Clarissa Consolandi, Eleonora Mangano, Paride Pelucchi, Ingrid Cifola, Tania Camboni, Marco Severgnini, Laura Villani, Barbara Tagliaferri, Stephana Carelli, Serenella M. Pupa, Cristina Cereda, Fabio Corsi
Format:	Article
Language:	English
Published:	BMC 2024-06-01
Subjects:	Breast cancer Patient-derived organoids Tumour evolution
Online Access:	https://doi.org/10.1186/s12935-024-03375-5